BB
INFI

BB Biotech’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BB Biotech’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,700,737
Closed -$14.2M – 31
2016
Q1 		$14.2M Hold
2,700,737
– – 0.57% 24
2015
Q4 		$21.2M Hold
2,700,737
– – 0.6% 25
2015
Q3 		$22.8M Hold
2,700,737
– – 0.72% 24
2015
Q2 		$29.6M Buy
2,700,737
+80,000
+3% +$1.03M 0.8% 24
2015
Q1 		$36.6M Buy
2,620,737
+300,000
+13% +$4.59M 1.09% 24
2014
Q4 		$39.2M Hold
2,320,737
– – 1.27% 21
2014
Q3 		$31.1M Buy
2,320,737
+815,000
+54% +$9.71M 1.27% 20
2014
Q2 		$19.2M Buy
1,505,737
+205,000
+16% +$2.14M 0.91% 21
2014
Q1 		$15.5M Hold
1,300,737
– – 0.8% 19
2013
Q4 		$18M Hold
1,300,737
– – 0.96% 18
2013
Q3 		$22.7M Buy
1,300,737
+210,909
+19% +$4.04M 1.23% 19
2013
Q2 		$17.6M Buy
+1,089,828
New +$33.7M 1.27% 15

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech's INFI Position: Q2 2016 in Review

BB Biotech sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 2,700,737 shares — an estimated $14.2M sold.

BB Biotech first reported a position in INFI in Q2 2013 and held it in 12 quarters. The position peaked at $39.2M in Q4 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • BB Biotech reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • BB Biotech sold 2,700,737 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $14.2M.
  • BB Biotech first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
  • BB Biotech's Infinity Pharmaceuticals, Inc. position peaked at $39.2M in Q4 2014.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on BB Biotech's 13F filing for Q2 2016, filed 12 Aug 2016.